Variola Major (Smallpox) Completed Phase 1 Trials for Smallpox (Vaccinia) Vaccine, Live (DB14711)

Also known as: Small Pox / Smallpox / Smallpox (disorder) / Variola major (disorder) / Smallpox, unspecified

IndicationStatusPhase
DBCOND0038255 (Variola Major (Smallpox))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05762523Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 YearsPrevention
NCT00336635Safety and Immunogenicity of CJ-50300Prevention
NCT00082446Combination Study With MVA BN and DryvaxPrevention
NCT00079820Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in AdultsPrevention
NCT00042094Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax®Prevention